Abcam plc

Molecular Instruments and Abcam Announce Broad Compatibility of the HCR™ HiFi Encoder with Abcam's Best-in-Class RabMAb® and Mouse Antibody Portfolio

Metabolism Assays Market Size Projected to Reach USD 3.1 Billion by 2034, Growing Steadily at 6.7% CAGR | Report by Transparency Market Research, Inc

Danaher completes $5.7 billion acquisition of Abcam

Danaher Completes Acquisition of Abcam

Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales

Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign

Jonathan Milner Issues Statement Responding to the Glass Lewis Report

Jonathan Milner Issues Statement Responding to ISS Report

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company

Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short

ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM

Jonathan Milner issues Open Letter to shareholders of Abcam plc

GMED or ABCM: Which Is the Better Value Stock Right Now?

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Abcam plc Statement on Dr. Jonathan Milner's Announcement

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board

Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023

ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM

Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings

ABCM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Abcam plc Is Fair to Shareholders